Drug Database
Back to search

Switzerland· 55214009

Actonel Wochentablette

A risedronic acid product containing natrii risedronas, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC M05BA07

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedActonel WochentabletteATCM05BA07REGISTER NO.55214009PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about natrii risedronasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Risedronic acid is registered in 14 of 19 countries.

Countries holding a registration under ATC M05BA07 (risedronic acid), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 8 of them publish a price we can compare per daily dose
Search risedronic acid products by name

Risedronic acid · ATC M05BA07

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of risedronic acid costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.45 in Italy to $1.17 in Switzerland — a ×2.6 gap.

  • Switzerland: $1.17 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Risedronic acid · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.17
  • IT Italy$0.45
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
natrii risedronas
Manufacturer
—
Country
Switzerland (CH)
ATC code
M05BA07
ATC class
Risedronic acid
Defined daily dose
5 mg, O
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680552140091
    4 Stk
    CHF 33.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

293 interactions on record for risedronic acid.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check risedronic acid against other medicinesHow interaction checks work

Risedronic acid · interactions on record

293 records

  • 2 severe
  • 68 moderate
  • 204 info

Most severe, free to view

  • EtelcalcetideH05BX04severe
  • DeferasiroxV03AC03severe
  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate

19 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Risedronic acid in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All risedronic acid products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Germany · Risedronat Al
  • France · Risedronate Eg
  • Italy · Risedronato Eg Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/331cbfb5-efb1-4763-843b-7b8b89d38536
GET /v1/drugs/331cbfb5-efb1-4763-843b-7b8b89d38536?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "natrii risedronas 35 mg",
  "valid_from": "2003-01-01",
  "limitations": "[{\"description\":\"Zur Behandlung von dokumentierter Osteoporose und von Patienten mit Paget-Krankheit der Knochen.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2024-10-01\",\"validTo\":null}]",
  "galenic_form": "Tabl 35 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2003-01-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about risedronic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console